EDBI, Pavilion Capital backed US-based Nuvation Bio's $275m Series A

EDBI, Pavilion Capital backed US-based Nuvation Bio's $275m Series A

Photo from Alphamab Oncology's website.

Kristie Neo

31 October, 2019

Pavilion CapitalTemasek

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from World

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.